ACCESSION: MSBNK-SMB_Measured-HSA015P0112014
RECORD_TITLE: Annotated; Cytosine; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was annotated at Level 2a automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 13
COMMENT: RAW_SPEC {'EL14_pos_1498': {'bp': 1374623.0, 'sum': 3149406.0}, 'EL13_pos_1493': {'bp': 1299742.0, 'sum': 3028207.0}, 'EL17_pos_1490': {'bp': 1298047.0, 'sum': 3152425.0}, 'EL18_pos_1493': {'bp': 1092639.0, 'sum': 2765809.0}, 'EL02_pos_1498': {'bp': 1007930.0, 'sum': 2852410.0}, 'EL15_pos_1495': {'bp': 884443.0, 'sum': 2615302.0}, 'EL19_pos_1504': {'bp': 874151.0, 'sum': 2659575.0}, 'EL16_pos_1496': {'bp': 839553.0, 'sum': 2578424.0}, 'EL20_pos_1491': {'bp': 804249.0, 'sum': 2452310.0}, 'EL01_pos_1498': {'bp': 777459.0, 'sum': 2321565.0}, 'EL08_pos_1499': {'bp': 568724.0, 'sum': 2079104.0}, 'EL21_pos_1496': {'bp': 550648.0, 'sum': 2144784.0}, 'EL06_pos_1499': {'bp': 537763.0, 'sum': 2234757.0}}
COMMENT: RETENTION_TIME_STDEV 0.004
COMMENT: PRECURSOR_M/Z_RAW 112.050882
COMMENT: PRECURSOR_M/Z_STDEV 0.000035
COMMENT: PRECURSOR_IN_MS1 mz 112.050450; int 17.888; delta(ppm) 0.665991
COMMENT: PROPOSED_CHARGE_STATE +1; mz 113.053799; int 0.759; cor 0.736
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.792; C4H5N3O; [M+H]+; delta(ppm) -0.792485
COMMENT: PROPOSED_MF MS-FINDER 3.754; C4H5N3O; [M+H]+; delta(ppm) -0.787463
COMMENT: PROPOSED_MF SIRIUS5_Sirius 9.860; C4H5N3O; [M+H]+; delta(ppm) -0.787463
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C4H5N3O; [M+H]+; delta(ppm) -0.787463
COMMENT: PROPOSED_MF SIRIUS6_Sirius 19.639; C4H5N3O; [M+H]+; delta(ppm) -0.787463
COMMENT: PROPOSED_MF SIRIUS6_Sirius 17.511; CH6FN3O2; [M+H]+; delta(ppm) -10.985016
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.374; C6H7O2; [M+H]+; delta(ppm) -12.769970
COMMENT: PROPOSED_MF SIRIUS6_Sirius 1.352; H8N4OP; [M+H]+; delta(ppm) -3.546057
COMMENT: PROPOSED_MF SIRIUS6_Sirius 1.190; C2H3N6; [M+H]+; delta(ppm) 11.195332
COMMENT: PROPOSED_MF SIRIUS6_Sirius -4.705; C4H6F3; [M+H]+; delta(ppm) 9.052939
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.996; C4H5N3O; [M+H]+; delta(ppm) -0.787463
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.004; CH6FN3O2; [M+H]+; delta(ppm) -10.985016
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 31.000; OPTASPLRGRRNAP-UHFFFAOYSA-N; C4H5N3O; CYTOSINE
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.311; ZBNZAJFNDPPMDT-UHFFFAOYSA-N; [M+H]+; NC(=O)C1=CNC=N1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.078; BNYCHCAYYYRJSH-UHFFFAOYSA-N; [M+H]+; C1=C(NN=C1)C(=O)N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.975; NMIZONYLXCOHEF-UHFFFAOYSA-N; [M+H]+; C1=CN=C(N1)C(=O)N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.867; DVLHGMFTRAFHPR-UHFFFAOYSA-N; [M+H]+; C1=CN(N=C1)C(=O)N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.844; BIXBBIPTYBJTRY-UHFFFAOYSA-N; [M+H]+; NC1=NC(=O)N2CC12
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.639; OPTASPLRGRRNAP-UHFFFAOYSA-N; [M+H]+; Cytosine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.038; XQCZBXHVTFVIFE-UHFFFAOYSA-N; [M+H]+; 2-amino-4-hydroxypyrimidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.904; BIXBBIPTYBJTRY-UHFFFAOYSA-N; [M+H]+; Imexon
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.825; ZBNZAJFNDPPMDT-UHFFFAOYSA-N; [M+H]+; UNPD207467
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.781; BNYCHCAYYYRJSH-UHFFFAOYSA-N; [M+H]+; 1H-pyrazole-5-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.755; KQLHRXQKORXSTC-UHFFFAOYSA-N; [M+H]+; 3-amino-1H-pyrazin-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.745; DVLHGMFTRAFHPR-UHFFFAOYSA-N; [M+H]+; pyrazole-1-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.725; QBKIGBNGDYTHNG-UHFFFAOYSA-N; [M+H]+; 4-amino-1,3-diazabicyclo[3.1.0]hex-4-en-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.683; NMIZONYLXCOHEF-UHFFFAOYSA-N; [M+H]+; 1H-imidazole-2-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.627; PRFAXWWHJWIUPI-UHFFFAOYSA-N; [M+H]+; 4-methoxytriazine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.528; FVWKFDRZDTWXGT-UHFFFAOYSA-N; [M+H]+; 5-diazenyl-1H-pyrrol-2-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.482; SMXZQOMVCREYNY-UHFFFAOYSA-N; [M+H]+; N-(1H-imidazol-2-yl)formamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.441; NCMONXLWVRSCBP-UHFFFAOYSA-N; [M+H]+; 2-methoxy-1,3,5-triazine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; QBKIGBNGDYTHNG-UHFFFAOYSA-N; [M+H]+; 4-amino-1,3-diazabicyclo[3.1.0]hex-4-en-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.999; BNYCHCAYYYRJSH-UHFFFAOYSA-N; [M+H]+; 1H-pyrazole-5-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.997; NMIZONYLXCOHEF-UHFFFAOYSA-N; [M+H]+; 1H-imidazole-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.980; KQLHRXQKORXSTC-UHFFFAOYSA-N; [M+H]+; 3-amino-1H-pyrazin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.849; FVWKFDRZDTWXGT-UHFFFAOYSA-N; [M+H]+; 5-diazenyl-1H-pyrrol-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.843; DVLHGMFTRAFHPR-UHFFFAOYSA-N; [M+H]+; pyrazole-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.839; ZBNZAJFNDPPMDT-UHFFFAOYSA-N; [M+H]+; UNPD207467
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.825; OPTASPLRGRRNAP-UHFFFAOYSA-N; [M+H]+; Cytosine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.822; XQCZBXHVTFVIFE-UHFFFAOYSA-N; [M+H]+; 2-amino-4-hydroxypyrimidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.790; BIXBBIPTYBJTRY-UHFFFAOYSA-N; [M+H]+; Imexon
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.705; SMXZQOMVCREYNY-UHFFFAOYSA-N; [M+H]+; N-(1H-imidazol-2-yl)formamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.123; PRFAXWWHJWIUPI-UHFFFAOYSA-N; [M+H]+; 4-methoxytriazine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.086; NCMONXLWVRSCBP-UHFFFAOYSA-N; [M+H]+; 2-methoxy-1,3,5-triazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.818; OPTASPLRGRRNAP-UHFFFAOYSA-N; [M+H]+; 6-amino-1H-pyrimidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.782; XQCZBXHVTFVIFE-UHFFFAOYSA-N; [M+H]+; 2-amino-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.428; BNYCHCAYYYRJSH-UHFFFAOYSA-N; [M+H]+; 1H-pyrazole-5-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.169; ZVXKYWHJBYIYNI-UHFFFAOYSA-N; [M+H]+; 1H-pyrazole-4-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.135; VROMXVIODDASTK-UHFFFAOYSA-N; [M+H]+; 5-amino-1H-pyridazin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.130; HFMLLTVIMFEQRE-UHFFFAOYSA-N; [M+H]+; 4-amino-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.127; MJSOXUAUMZKRAK-UHFFFAOYSA-N; [M+H]+; 4-amino-1H-pyridazin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.127; XWLBYEBHQNSCKA-UHFFFAOYSA-N; [M+H]+; 5-amino-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.094; JWYFWQDQLAEMAF-UHFFFAOYSA-N; [M+H]+; 6-amino-1H-pyrazin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.094; RMSRKYVNQYEPHO-UHFFFAOYSA-N; [M+H]+; 2-cyanoaziridine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.079; BIXBBIPTYBJTRY-UHFFFAOYSA-N; [M+H]+; 4-amino-1,3-diazabicyclo[3.1.0]hex-3-en-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.065; ZBNZAJFNDPPMDT-UHFFFAOYSA-N; [M+H]+; 1H-imidazole-5-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.048; VTYNJTABFCXTBH-UHFFFAOYSA-N; [M+H]+; 1,2-oxazole-3-carboximidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.012; MMZLICVOTDAZOX-UHFFFAOYSA-N; [M+H]+; 3-amino-1H-pyridazin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.927; NVYMOVCPYONOSF-UHFFFAOYSA-N; [M+H]+; 2-aminopyrimidin-5-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.913; QPISWILGPJGWLV-UHFFFAOYSA-N; [M+H]+; 4-aminopyrimidin-5-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.910; CWNBIZNFVWOUFW-UHFFFAOYSA-N; [M+H]+; 5-amino-1H-pyrazole-4-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.835; SMXZQOMVCREYNY-UHFFFAOYSA-N; [M+H]+; N-(1H-imidazol-2-yl)formamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.748; JFSBTWPIEZSDPR-UHFFFAOYSA-N; [M+H]+; 5-methyl-2H-triazole-4-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.741; TXNWXXKJPZYOKA-UHFFFAOYSA-N; [M+H]+; 5-methyl-1H-1,2,4-triazole-3-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.733; GYKQWOBXJHLLAP-UHFFFAOYSA-N; [M+H]+; 1-(1H-1,2,4-triazol-5-yl)ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.448; BJDKLXOVGAGGHJ-UHFFFAOYSA-N; [M+H]+; 4-ethenyl-1H-1,2,4-triazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.442; PDWZJMKDSKSWMD-UHFFFAOYSA-N; [M+H]+; 6-methyl-4H-1,2,4-triazin-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.392; FRJSHBUKQSGJNG-UHFFFAOYSA-N; [M+H]+; 1-methyltriazole-4-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.390; VFAQDMYUCHBIJL-UHFFFAOYSA-N; [M+H]+; 3-methyltriazole-4-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.382; OJBNZAZUTPLWDT-UHFFFAOYSA-N; [M+H]+; 2-methyl-1,2,4-triazole-3-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.380; NLBSACQGJDXXNQ-UHFFFAOYSA-N; [M+H]+; 1-methyl-1,2,4-triazole-3-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.379; ADIHVKJNUPTHMC-UHFFFAOYSA-N; [M+H]+; 2-methyltriazole-4-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.375; YWHCWSOBIXRMBY-UHFFFAOYSA-N; [M+H]+; 4-methyl-1,2,4-triazole-3-carbaldehyde
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -9.025; OPTASPLRGRRNAP; [M+H]+; cytosine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -85.766; HFMLLTVIMFEQRE; [M+H]+; zlchem 81
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -92.237; XQCZBXHVTFVIFE; [M+H]+; zlchem 273
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -136.965; XWLBYEBHQNSCKA; [M+H]+; 5-aminopyrimidin-4-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -145.121; NVYMOVCPYONOSF; [M+H]+; zlchem 1241
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -162.328; NCMONXLWVRSCBP; [M+H]+; 2-methoxy-1,3,5-triazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -195.007; NMIZONYLXCOHEF; [M+H]+; Imidazolcarboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -197.440; FRJSHBUKQSGJNG; [M+H]+; 1-methyl-1H-1,2,3-triazole-4-carbaldehyde
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -199.066; ZBNZAJFNDPPMDT; [M+H]+; Imidazole-4-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -199.402; BNYCHCAYYYRJSH; [M+H]+; Pyrazole-3-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -202.731; PDWZJMKDSKSWMD; [M+H]+; 6-methyl-1,2,4-triazin-5-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -218.279; NLBSACQGJDXXNQ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -222.234; BJDKLXOVGAGGHJ; [M+H]+; 4-Vinyl-1,2,4-triazol-3-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -226.102; OJBNZAZUTPLWDT; [M+H]+; 1-methyl-1H-1,2,4-triazole-5-carbaldehyde
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -230.222; YWHCWSOBIXRMBY; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -244.922; DQGMASZUGMDEFA; [M+H]+; 1-Methyl-2-nitrosoimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -252.262; RMSRKYVNQYEPHO; [M+H]+; N-(2-Cyanoethylene)urea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -264.884; BIXBBIPTYBJTRY; [M+H]+; Imexonum
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.849; OPTASPLRGRRNAP; [M+H]+; cytosine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -19.565; OPTASPLRGRRNAP; [M+H]+; Zytosin
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -50.942; MJSOXUAUMZKRAK; [M+H]+; 5-Aminopyridazin-3(2h)-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -57.765; XQCZBXHVTFVIFE; [M+H]+; 2-amino-1,4-dihydropyrimidin-4-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -59.425; ZVXKYWHJBYIYNI; [M+H]+; 1H-pyrazol-2-ium-4-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -66.743; CWNBIZNFVWOUFW; [M+H]+; 3-Aminopyrazole-4-carbaldehyde
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -68.609; JWYFWQDQLAEMAF; [M+H]+; 6-Aminopyrazin-2-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -70.857; NMIZONYLXCOHEF; [M+H]+; 1H-Imidazole-2-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -72.346; HFMLLTVIMFEQRE; [M+H]+; 4-Amino-6-hydroxypyrimidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -72.427; XWLBYEBHQNSCKA; [M+H]+; 5-Amino-4-hydroxypyrimidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -73.383; KQLHRXQKORXSTC; [M+H]+; 3-Aminopyrazin-2-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.861; OPTASPLRGRRNAP; [M+H]+; Zytosin
COMMENT: CONFIDENCE Level 2a: Probable structure by library spectrum match Cytosine, OPTASPLRGRRNAP-UHFFFAOYSA-N; Matching to 31 measured spectra (Dot product > 0.7); Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (8), MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0000630;
CH$NAME: Cytosine
CH$NAME: 6-amino-1H-pyrimidin-2-one
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C4H5N3O
CH$EXACT_MASS: 111.043262
CH$SMILES: C1=C(NC(=O)N=C1)N
CH$IUPAC: InChI=1S/C4H5N3O/c5-3-1-2-6-4(8)7-3/h1-2H,(H3,5,6,7,8)
CH$LINK: CHEBI CHEBI:16040
CH$LINK: HMDB HMDB0000630
CH$LINK: INCHIKEY OPTASPLRGRRNAP-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:597
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 2.408
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 112.050450
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-03di-4900000000-a1fccff282e99e7d82ec
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  55.0545130 38.3904 55.055221 0.4541 15.06 -0.1399 12 ?
  67.0543916 37.5040 67.055133 0.3430 13.73 -0.1264 13 ?
  68.0133216 9.2478 68.014064 1.2645 1.93 0.7818 10 f{C3H2N1O1}/3.40ppm,p-C1H4N2
  68.0496351 19.2957 68.050377 0.5437 7.54 -0.5385 12 f{C4H6N1}/2.34ppm,p-N2O1
  69.0336408 56.3867 69.034384 0.4056 21.55 -0.2473 13 f{C4H5O1}/2.17ppm,p-H1N3
  69.0448470 81.8811 69.045590 0.3911 5.80 0.9396 13 f{C3H5N2}/1.77ppm,p-C1H1N1O1
  69.0700139 52.8360 69.070757 0.5502 20.29 -0.2967 13 ?
  70.0652329 23.8288 70.065976 0.8135 10.51 -0.5440 13 ?
  71.0494208 9.9212 71.050164 1.7734 3.07 0.5758 10 ?
  72.0808971 29.1619 72.081640 0.5549 14.91 -0.7692 13 ?
  72.9372068 32.3669 72.937949 0.7678 10.83 -0.0769 13 ?
  79.0542809 66.5138 79.055013 0.4554 23.90 -0.1154 13 ?
  80.9450924 16.6464 80.945819 1.1242 4.03 0.4266 12 ?
  83.0492875 12.7677 83.050007 1.2643 3.85 0.3818 10 ?
  84.0809914 7.5251 84.081707 1.6413 2.28 0.3846 13 ?
  86.0966517 5.4945 86.097358 1.7190 2.57 -0.2587 12 ?
  93.0448105 19.2150 93.045477 1.0318 10.42 -0.7818 11 ?
  94.0400138 34.0845 94.040674 1.0208 2.75 0.9560 13 f{C4H4N3}/0.43ppm,p-H2O1
  94.0652471 8.3916 94.065907 1.6478 4.06 -0.2912 13 ?
  95.0239917 245.8816 95.024645 0.3578 9.03 0.9945 13 f{C4H3N2O1}/0.03ppm,p-H3N1
  95.0491700 12.2252 95.049823 1.1783 4.93 -0.0455 11 ?
  95.0604857 16.0767 95.061138 0.9888 6.98 0.0839 12 ?
  96.0807651 43.6605 96.081410 0.6349 19.49 -0.4066 13 ?
  97.0648428 15.2235 97.065480 1.3187 6.08 0.0165 13 ?
  110.0601013 84.4830 110.060623 0.5633 24.16 0.3297 13 ?
  110.0794898 18.6839 110.080011 0.9175 8.80 -0.5769 13 ?
  111.0441146 16.9174 111.044629 1.1437 7.73 -0.5315 12 ?
  111.0553222 31.8365 111.055837 0.5763 17.31 -0.8252 12 ?
  111.0634600 11.0520 111.063975 0.6933 3.65 0.0636 11 ?
  111.0804911 13.5446 111.081005 1.3234 5.22 0.1374 13 ?
  112.0505807 999.0000 112.051088 0.3570 0.00 1.0000 13 f{C4H6N3O1}/0.38ppm,p
  112.0756155 32.8304 112.076122 0.6692 10.27 0.2967 13 ?
  112.1120919 8.7352 112.112599 1.4361 3.14 0.0879 13 ?
  112.9997830 7.5681 113.000283 1.6018 4.03 -0.0364 11 ?
  113.0233097 23.7583 113.023809 0.9202 9.00 -0.0559 12 ?
  113.0347766 12.4925 113.035276 1.2828 4.37 0.3091 10 ?
  113.0472107 7.3592 113.047710 0.4158 1.90 0.7818 10 ?
  113.0537333 33.8194 113.054232 0.7784 4.83 0.9790 12 ?
  113.0598546 49.6520 113.060354 0.7695 22.23 -0.5934 13 ?
  113.0711329 4.8823 113.071632 1.0082 1.73 0.3818 10 ?
  113.1073035 67.0937 113.107802 0.5393 30.13 -0.7692 13 ?
  114.0913298 443.7662 114.091821 0.3331 154.63 -0.1044 13 ?
  116.9660955 16.2068 116.966562 0.9746 7.65 -0.6154 13 ?
  130.9818625 16.6233 130.982186 1.4659 5.66 0.0210 12 ?
PK$NUM_PEAK: 44
PK$PEAK: m/z int. rel.int.
  55.054513 38.39 38
  67.054392 37.50 37
  68.013322 9.25 9
  68.049635 19.30 19
  69.033641 56.39 56
  69.044847 81.88 81
  69.070014 52.84 52
  70.065233 23.83 23
  71.049421 9.92 9
  72.080897 29.16 29
  72.937207 32.37 32
  79.054281 66.51 66
  80.945092 16.65 16
  83.049287 12.77 12
  84.080991 7.53 7
  86.096652 5.49 5
  93.044810 19.21 19
  94.040014 34.08 34
  94.065247 8.39 8
  95.023992 245.88 245
  95.049170 12.23 12
  95.060486 16.08 16
  96.080765 43.66 43
  97.064843 15.22 15
  110.060101 84.48 84
  110.079490 18.68 18
  111.044115 16.92 16
  111.055322 31.84 31
  111.063460 11.05 11
  111.080491 13.54 13
  112.050581 999.00 999
  112.075615 32.83 32
  112.112092 8.74 8
  112.999783 7.57 7
  113.023310 23.76 23
  113.034777 12.49 12
  113.047211 7.36 7
  113.053733 33.82 33
  113.059855 49.65 49
  113.071133 4.88 4
  113.107303 67.09 67
  114.091330 443.77 443
  116.966096 16.21 16
  130.981863 16.62 16
//
